Clinical Trials Directory

Trials / Completed

CompletedNCT05897671

Foveal Sparing ILM Peeling With ILM Flap Transposition

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Vienna Institute for Research in Ocular Surgery · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Foveal sparing internal limiting membrane (ILM) peeling with ILM flap transposition over the macular hole combines the benefits of foveal sparing ILM peeling with ILM flap techniques. Aim of this study is to retrospectively examine the rate of postsurgical macular hole closure, development of central atrophy in the foveal area, and improvement of best corrected distant visual acuity in a group of patients having undergone foveal sparing ILM peeling with ILM flap transposition for macular hole repair.

Detailed description

Idiopathic full thickness macular holes lead to central defects in the visual field and to deterioration of the visual acuity. Introduction of internal limiting membrane (ILM) Peeling techniques lead to significant increase in closure rates of the macular holes. Foveal sparing ILM peeling represents a surgical technique for macular hole repair with less surgical trauma with high closure rates of the macular hole, compared to classic ILM Peeling \[Ho et al. 2014, Murphy et al 2019\]. The combination of foveal sparing ILM Peeling with the established ILM flap techniques \[Michalewska et al 2010 und 2015\] offers the potential of better improvement in postsurgical visual acuity with the high closure rates, due to ILM flaps. Aim of this study is to retrospectively examine the rate of postsurgical macular hole closure, development of central atrophy in the foveal area, and improvement of best corrected distant visual acuity in a group of patients having undergone foveal sparing ILM peeling with ILM flap transposition for macular hole repair.

Conditions

Interventions

TypeNameDescription
OTHERretrospective data analysisMacular hole closure rate, visual acuity and OCT

Timeline

Start date
2023-06-01
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2023-06-09
Last updated
2023-06-13

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT05897671. Inclusion in this directory is not an endorsement.